Glymphatic Dysfunction, Brain Damage, and Clinical Disability in Spinocerebellar Ataxia Type 3
Movement Disorders · 2026
DOI: 10.1002/mds.70311 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Jing Guo und 11 weiteren Autor:innen. Beteiligte Einrichtung: 7T Magnetic Resonance Translational Medicine Research Center, Department of Radiology, Southwest Hospital, Army Medical University (Third Military Me…. Hauptthemen laut MEDLINE: Machado-Joseph Disease, Glymphatic System, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Young and Middle-aged Senior Medical Talents studio of Chongqing, Senior Medical Talents Program of Chongqing for.
Abstract (Originalsprache)
Background
The glymphatic system, a key fluid clearance pathway in the central nervous system, is emerging as a potential therapeutic target for synucleinopathies. Dysregulation of this system may contribute to spinocerebellar ataxia type 3 (SCA3) pathogenesis, in which the accumulation of misfolded proteins acts as a central driver.
Objectives
The goal was to investigate glymphatic system function in SCA3 patients and evaluate its relationship with brain damage and clinical disability.
Methods
Ninety‐two SCA3 patients (14 with premanifest SCA3 and 78 with manifest SCA3) and 98 healthy controls underwent clinical evaluation and magnetic resonance imaging (MRI) scans. MRI parameters, including the diffusion along the perivascular space (DTI‐ALPS) index (a proxy for glymphatic function); cerebral, cerebellar, and subcortical gray matter volumes; and whole‐brain microstructural properties of white matter, were calculated.
Results
Patients with premanifest and manifest SCA3 had lower ALPS indices compared with healthy controls, and patients with manifest SCA3 had a lower ALPS index compared with premanifest SCA3. In SCA3 patients, lower ALPS index was associated with more severe disability and longer disease duration. A negative correlation between ALPS and disease duration emerged after 3 years, with no significant association observed before the 3‐year cutoff. Moreover, lower ALPS index was correlated with more pronounced cortical and subcortical gray matter atrophy, decreased fractional anisotropy, and elevated mean diffusivity in white matter.
Conclusions
Our findings demonstrate that glymphatic function is impaired, particularly in the presymptomatic stage of SCA3, and this impairment is associated with disability, neurodegeneration, and demyelination. Therefore, glymphatic dysfunction may contribute to the pathogenesis of SCA3. © 2026 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 7T Magnetic Resonance Translational Medicine Research Center, Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
- The Clinical Hospital of Chengdu Brain Science Institute, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China.
- MOE Key Lab for Neuroinformation, High-Field Magnetic Resonance Brain Imaging Key Laboratory of Sichuan Province, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey, USA.
- Department of Neurology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
- MR Research Collaboration Team, Siemens Healthineers, Chengdu, China.
ORCID-Profile: Jun Xie, Bharat B Biswal, Wei Chen, Jian Wang
Förderung
- National Natural Science Foundation of China
- Young and Middle-aged Senior Medical Talents studio of Chongqing
- Senior Medical Talents Program of Chongqing for
- Sichuan Province Science and Technology Support Program
- Excellent Young Talent Fund of the First Affiliated Hospital of the Army Medical
- Postdoctoral Research Fund of the First Affiliated
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Guo, J., Xie, J., Fan, Y., Biswal, B. B., Liu, X., Wang, X., Sheng, W., Chen, W., Chen, H., Wang, J., Huang, W., & Liu, C. (2026). Glymphatic Dysfunction, Brain Damage, and Clinical Disability in Spinocerebellar Ataxia Type 3. Movement Disorders. https://doi.org/10.1002/mds.70311
Vancouver
Guo J, Xie J, Fan Y, Biswal BB, Liu X, Wang X, et al. Glymphatic Dysfunction, Brain Damage, and Clinical Disability in Spinocerebellar Ataxia Type 3. Movement Disorders. 2026. doi:10.1002/mds.70311
BibTeX
@article{Guo2026,
author = {Guo, Jing and Xie, Jun and Fan, Yunshuang and Biswal, Bharat B and Liu, Xinyuan and Wang, Xingang and Sheng, Wei and Chen, Wei and Chen, Huafu and Wang, Jian and Huang, Wei and Liu, Chen},
title = {Glymphatic Dysfunction, Brain Damage, and Clinical Disability in Spinocerebellar Ataxia Type 3},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70311}
}
EUVIMED